Sheepish about social networking

Flickr photo by pasotraspaso.

I was reading this morning about a new obesity drug that has Wall Street analysts gravely disappointed. It seems that after years of clinical trials, the drug passed two of three important tests with flying colors. It helped lower cholesterol and, if that wasn't enough, it didn't appear to cause heart-valve failure. It sounds like a winner so far.

The one test it failed, however, was a doozy. The weight-loss drug did not result in people actually losing weight.

more...

To continue reading sign in to your Premium Member account.

Premium Members have full access to all news archives.

Buy Now Purchase 1-year Premium Membership - $149.95

OR

Buy Now Purchase Monthly Premium Membership - $19.95

All rights reserved. This article may not be used or reproduced in any manner whatsoever, in part or in whole, without written permission of Inman News. Use of this article without permission is a violation of federal copyright law.